Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine

Human Gene Therapy

Volumn 9, Issue 6, 1998, Pages 835-843

  Thomas, Matthew C ^a   Greten, Tim F ^a   Pardoll, Drew M ^a   Jaffee, Elizabeth M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; AUTOANTIGEN; CANCER VACCINE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR CELL VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOLOGY; CANCER PREVENTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHASE 1 CLINICAL TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; TUMOR CELL; TUMOR IMMUNITY;

ANIMALIA; MURINAE;

EID: 0032503016     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.6-835     Document Type: Article

References (11)

1. BEVAN, M.J. (1976). Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J Immunol. 117, 2233-2238.
2. BEVAN, M.J. (1995). Antigen presentation to cytotoxic T lymphocytes in vivo. J. Exp. Med. 182, 639-641.
3. BOON, T., and VAN DER BRUGGEN, P. (1996). Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183, 725-729.
4. CHEN, L., LINSLEY, P.S., and HELLSTROM, K.E. (1993). Costimulation of T cells for tumor immunity. Immunol. Today 14, 483-486.
5. CORBETT, T.H., GRISWOLD, D.J., ROBERTS, B.J., PECKHAM, J.C., and SCHABEL, F.J. (1975). Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res. 35, 2434-2439.
6. DRANOFF, G., JAFFEE, E.M., LAZENBY, A., GOLUMBECK, P., LEVITSKY, H.I., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D.M., and MULLIGAN, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocytemacrophage colony stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. U.S.A. 90, 3539-3543.
7. FIDLER, I.J. (1975). Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 35, 218-224.
8. GRAF, L.J., KAPLAN, P., and SILAGI, S. (1984). Efficient DNA-mediated transfer of selectable genes and unselected sequences into differentiated and undifferentiated mouse melanoma clones. Somatic Cell Mol. Genet. 10, 139-151.
9. GRISWOLD, D.P., and CORBETT, T.H. (1975). A colon tumor model for anticancer agent evaluation. Cancer 36, 2441-2444.
10. HOLMES, K.L., PALASZYNSKI, E., FREDRICKSON, T.N., MORSE, H.D., and IHLE, J.N. (1985). Correlation of cell-surface phenotype with the establishment of interleukin 3-dependent cell lines from wild-mouse murine leukemia virus-induced neoplasms. Proc. Natl. Acad. Sci. U.S.A. 82, 6687-6691.
11. TOES, R.E., BLOM, R.J., VAN DER VOORT, E., OFFRINGA, R., MELIEF, C.J., and KAST, W.M. (1996). Protective antitumor immunity induced by immunization with completely allogeneic tumor cells. Cancer Res. 56, 3782-3787.